The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Molecular mechanisms regulating NLRP3 inflammasome activation
Open accessAbstract
Inflammasomes are multi-protein signaling complexes that trigger the activation of inflammatory caspases and the maturation of interleukin-1β. Among various inflammasome complexes, the NLRP3 inflammasome is best characterized and has been linked with various human autoinflammatory and autoimmune diseases. Thus, the NLRP3 inflammasome may be a promising target for anti-inflammatory therapies. In this review, we summarize the current understanding of the mechanisms by which the NLRP3 inflammasome is activated in the cytosol. We also describe the binding partners of NLRP3 inflammasome complexes activating or inhibiting the inflammasome assembly. Our knowledge of the mechanisms regulating NLRP3 inflammasome signaling and how these influence inflammatory responses offers further insight into potential therapeutic strategies to treat inflammatory diseases associated with dysregulation of the NLRP3 inflammasome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In these circumstances, ATP may act as DAMP, which activates the nuclear transcription factor NF-κB resulting in expression upregulation of pro-IL-1β and pro-IL-18 and the NLRP3 protein [16, 71].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [71]
In the citing paper
“Consequently, there is an activation of caspase-1 and maturation of IL-1β and IL-18, resulting in pro-inflammatory cytokine release [16, 20, 52, 71, 73].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [71]
Citations
Cites
1 retracted
UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
RetractedMartinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,444
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,001
Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver
Ezhilarasan, D. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30956 · Cited by 18
Chittasupho, C., Srisawad, K., Arjsri, P., Phongpradist, R., Tingya, W., Ampasavate, C., & Dejkriengkraikul, P. (2023) · Pharmaceuticals · doi:10.3390/ph16060862 · Cited by 18
Huang, W., Zhang, Y., Zheng, B., Ling, X., Wang, G., Li, L., Wang, W., Pan, M., Li, X., & Meng, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111017 · Cited by 18
Mirabedini, Z., Mirjalali, H., Kazemirad, E., Khamesipour, A., Samimi‐Rad, K., Koosha, M., Saberi, R., Rahimi, H. M., Mohebali, M., & Hajjaran, H. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03140-0 · Cited by 18
Inflammasomes at the crossroads of traumatic brain injury and post-traumatic epilepsy
Javalgekar, M., Jupp, B., Vivash, L. E., O'Brien, T. J., Wright, D. K., Jones, N. C., & Ali, I. Y. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03167-8 · Cited by 19
Li, S., Wang, M., Ojcius, D. M., BiJun, Z., Hu, W., Liu, Y., Ma, Q., Tang, G., Wang, D., & Yan, J. (2018) · Microbes and Infection · doi:10.1016/j.micinf.2018.01.010 · Cited by 19
Pirzgalska, R. M., & Domingos, A. I. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.04.014 · Cited by 18
Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo
Zhang, X., Huang, H., Zhang, G., Li, D., Wang, H., & Jiang, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00903 · Cited by 20
Yin, X., Wu, H., Zhang, B., Zhu, N., Chen, T., Ma, X., Zhang, L., Lv, L. L., Zhang, M., Wang, F., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14631 · Cited by 18
Regulated Cell Death in Pulpitis
Huang, M., Zhan, C., Yang, X., & Hou, J. L. (2020) · Journal of Endodontics · doi:10.1016/j.joen.2020.07.006 · Cited by 20
Hirsch, Y., Geraghty, J. R., Katz, E. A., & Testai, F. D. (2020) · Neurocritical Care · doi:10.1007/s12028-020-01113-z · Cited by 18
Fang, Y., Peng, D., Liang, Y., Lu, L., Li, J., Zhao, L., Ou, S., Li, S., Aschner, M., & Jiang, Y. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02471-7 · Cited by 18
Xiao, Z., Hu, S., Xu, W., Wang, S., Mo, W., Deng, H., Wei, J., Yang, H., Zhou, W., Li, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053658 · Cited by 18
Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation
Beesetti, S. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25970 · Cited by 18
Veltman, D., Laeremans, T., Passante, E., & Huber, H. J. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2016.12.016 · Cited by 17
Baral, A., & Park, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212589 · Cited by 17
Niu, X., Song, H., Xiao, X., Yu, J., Yu, J., Yang, Y., Huang, Q., Zang, L., Han, T., Zhang, D., et al. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2073890 · Cited by 17
Aydın, P., Aksakalli-Magden, Z. B., Uzunçakmak, S. K., Halıcı, H., Akgun, N., Mendĭl, A. S., Mokhtare, B., & Çadırcı, E. (2022) · Lung · doi:10.1007/s00408-022-00564-9 · Cited by 17
Leptin-depended NLRP3 inflammasome activation in osteoarthritic chondrocytes is mediated by ROS
Mourmoura, E., Papathanasiou, I. V., Trachana, V., Konteles, V., Tsoumpou, A., Goutas, A., Papageorgiou, A.-A., Stefanou, N., & Tsezou, A. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111730 · Cited by 17
Zhang, Z., Chen, Y., Zheng, Y., Wang, L., Shen, S., Yang, G., Yang, Y., & Wang, T. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221138534 · Cited by 19
Lo, C., Yen, C., Chen, C.-Y., Chen, H., & Lii, C. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116424 · Cited by 17
Fraile‐Μartinez, O., Montero, C. G., Pekarek, L., Saz, J. V., Álvarez-Mon, M. Á., Barrena-Blázquez, S., García‐Honduvilla, N., Buján, J., Asúnsolo, Á., Coca, S., et al. (2024) · PubMed · doi:10.14670/hh-18-617 · Cited by 17
Zhou, X. Y., Thai, M., Roediger, D. J., Mueller, B. A., Cullen, K. R., Klimes‐Dougan, B., & Andreazza, A. C. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.08.039 · Cited by 17
Qiang, J., Yang, R., Li, X., Xu, X., Zhou, M., Ji, X., Lu, Y., & Dong, Z. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111432 · Cited by 17
Chang, L., Xu, L., Tian, Y., Liu, Z., Song, M., Li, S., Zhang, X., Chen, Y., Hao, Q., Lu, Y., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167035 · Cited by 17
Huang, J., Hu, X., Li, J., & Gong, D. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03045-3 · Cited by 19
A Novel Catalase Nanogels for Effective Treatment of Neutrophilic Asthma
Xu, Z., Guo, X., Gu, Y., Zhao, D., Zou, Z., Shen, Y., He, C., Rong, Y., Xu, C., & Wang, F. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202316496 · Cited by 17
Molecular regulation of NLRP3 inflammasome activation during parasitic infection
Alonaizan, R. (2024) · Bioscience Reports · doi:10.1042/bsr20231918 · Cited by 18
Oraby, M. A., Mageed, S. S. A., Raouf, A. A., Abdelshafy, D. A., Ahmed, E. F., Khalil, R. T., Mangoura, S. A., & Fadaly, D. S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112465 · Cited by 18
Klarström-Engström, K., Zhang, B., & Demirel, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-38691-8 · Cited by 17
FUN14 domain‐containing 1-mediated mitophagy suppresses interleukin-1β production in macrophages
Huang, J., Zhu, T., Rong, R., You, M., Ji, D., & Li, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106964 · Cited by 17
Fatima, A., Connaughton, R. M., Weiser, A., Murphy, A. M., O’Grada, C. M., Ryan, M., Brennan, L., Gaora, P. Ó., & Roche, H. M. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700388 · Cited by 17
Niu, Z., Liu, Y., Zhou, D., Feng, J., Hu, Y., He, Z., Shen, T., Piao, J., Wu, H., & Hu, W. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.120458 · Cited by 16
S100 proteins as a key immunoregulatory mechanism for NLRP3 inflammasome
Acter, S., & Lin, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1663547 · Cited by 19
Liao, X., Wang, Y., Zhang, Z., Qu, X., & Zhou, G. (2026) · Mediators of Inflammation · doi:10.1155/mi/3168669 · Cited by 24
Lee, S. J., Kim, J. E., Choi, Y. J., Gong, J. E., Park, S. H., Douangdeuane, B., Souliya, O., Park, J. M., Lee, H. S., Kim, B.-H., et al. (2021) · Antioxidants · doi:10.3390/antiox10050791 · Cited by 16
Self-citationWang, J.-Y., Xing, Y.-X., Li, M.-Y., Zhang, Z.-H., Jin, H.-L., Ma, J., Lee, J., Zhong, Y., Zuo, H.-X., & Jin, X.-J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114715 · Cited by 16
Ding, X., Pu, Y., Tang, M., & Zhang, T. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159329 · Cited by 17
Saha, P., Upright, M., Bose, D., Roy, S., Trivedi, A., More, M., Scott, G., Brooks, B. W., & Chatterjee, S. (2022) · Toxins · doi:10.3390/toxins14120835 · Cited by 17
Tivantinib alleviates inflammatory diseases by directly targeting NLRP3
Huang, Y., Guo, Y., Zhou, Y., Huang, Q., Ru, Y., Luo, Y., & Xu, W. (2023) · iScience · doi:10.1016/j.isci.2023.106062 · Cited by 16
Bilirubin induces microglial NLRP3 inflammasome activation in vitro and in vivo
Ercan, İ., Mıçılı, S. Ç., Soy, S., Engür, D., Tüfekçi, K. U., Kumral, A., & Genç, Ş. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103850 · Cited by 16
Huang, Y., Wang, A., Jin, S., Liu, F., & Xu, F. (2023) · Allergologia et Immunopathologia · doi:10.15586/aei.v51i3.668 · Cited by 16
Mahmoud, M. F., Elrashidy, R. A., Mohammed, H. O., Drissi, B., Mahdi, I., & Sobeh, M. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105641 · Cited by 16
Zhao, J., Lu, N., Qu, Y., Liu, W., Zhong, H., Tang, N., Li, J., Wang, L., Xi, D., & He, F. (2024) · Experimental Biology and Medicine · doi:10.3389/ebm.2024.10112 · Cited by 16
Su, H.-Y., Zou, R., Su, J., Chen, X., Yang, H., An, N., Yang, C., Tang, J., Liu, J., & Yao, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387292 · Cited by 16
Lysosomal membrane permeabilization causes secretion of IL-1β in human vascular smooth muscle cells
Ono, H., Ohta, R., Kawasaki, Y., Niwa, A., Takada, H., Nakahata, T., Ohga, S., & Saito, M. K. (2018) · Inflammation Research · doi:10.1007/s00011-018-1178-z · Cited by 16
Ha, J. S., Yeom, Y.-S., Jang, J.-H., Kim, Y., Im, J. I., Kim, I. S., & Yang, S.-J. (2019) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2019.25.1.92 · Cited by 16
Castejón, M. L., Montoya, T., Alarcón‐de‐la‐Lastra, C., González‐Benjumea, A., Vázquez‐Román, V., & Sánchéz‐Hidalgo, M. (2020) · Food & Function · doi:10.1039/d0fo00235f · Cited by 16
Xie, H., Yang, L., Yang, Y., Jiang, W., Wang, X., Huang, M., Zhang, J., & Zhu, Q. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111439 · Cited by 16
Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis
Graustein, A. D., Berrington, W. R., Buckingham, K. J., Nguyen, F. K., Joudeh, L. L., Rosenfeld, M., Bamshad, M. J., Gibson, R. L., Hawn, T. R., & Emond, M. J. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0257oc · Cited by 14
The Nlrp3 inflammasome – the evolving story of its positive and negative effects on hematopoiesis
Ratajczak, M. Z., & Kucia, M. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000658 · Cited by 16
Zhang, Y., Liu, Y., Bi, X., Hu, C., & Ding, W. Q. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000513739 · Cited by 16
Skin Wounding–Induced Monocyte Expansion in Mice Is Not Abrogated by IL-1 Receptor 1 Deficiency
Barman, P. K., Pang, J., Urao, N., & Koh, T. J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801481 · Cited by 16
Yang, M., Lu, L., Kang, Z., Ma, T., & Wang, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4349 · Cited by 16
Guo, C., He, Y., Gai, L., Qu, J., Shi, Y., Xu, W., Cai, Y., Wang, B. L., Zhang, J., Zhao, Z., et al. (2020) · Food & Function · doi:10.1039/c9fo02494h · Cited by 16
The different faces of the NLRP3 inflammasome in cutaneous Leishmaniasis: A review
Kihel, A., Hammi, I., Darif, D., Lemrani, M., Riyad, M., Guessous, F., & Akarid, K. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155248 · Cited by 16
Dimethyl fumarate covalently modifies Cys673 of NLRP3 to exert anti-inflammatory effects
Hu, H., Cai, Y., Shi, Y., Zhang, S., Yu, X., Ma, T., & Liao, S. (2024) · iScience · doi:10.1016/j.isci.2024.109544 · Cited by 15
Inflammasomes as the molecular hub of cardiovascular-metabolic-immune comorbidity networks
Qian, X., Sun, J. M., Li, F., Li, X., Hu, X., Dong, N., & Li, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690443 · Cited by 18
Gaire, B. P., Koronyo, Y., Vit, J., Hutton, A., Subedi, L., Fuchs, D.-T. S., Swerdlow, N., Rentsendorj, A., Shahin, S., Martinon, D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68580-4 · Cited by 16
Downregulation of ROCK2 attenuates alcohol-induced inflammation and oxidative stress in astrocytes
Li, X., Tong, J., Liu, J., & Wang, Y. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1825421 · Cited by 15
Qoreishi, M., Panahi, M., Dorodi, O., Ghanbari, N., & Jousheghan, S. S. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02232-4 · Cited by 16
Lou, X., Ren, T., Chen, H., Huan, S., Yuan, L., & Zhang, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121657 · Cited by 15
Effects of estradiol on the virulence traits of Porphyromonas gingivalis
Demirel, K. J., Guimarães, A. N., & Demirel, I. (2022) · Scientific Reports · doi:10.1038/s41598-022-17019-z · Cited by 15
Wu, Z., Ma, L., Lin, P., Dai, Z., Lu, Z., Yan, L., Zhou, C., Qian, Z., Hong, P., & Li, C. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.115 · Cited by 15
The emerging role of pyroptosis in neuropathic pain
Li, B., Guo, J., Zhou, X., Li, W., Wang, N., Cao, R., & Cui, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110562 · Cited by 14
Yu, W., Jiang, W., Wu, W., Wang, G., Zhao, D., Yan, C., & Lin, P. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175911 · Cited by 15
Zhou, Y., Yang, Z., Ou, Y., Cai, H., Liu, Z., Lin, G., Liang, S., Hua, L., Yan, Y., Zhang, X., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04881-x · Cited by 15
Immune landscape and redox imbalance during neurological disorders in COVID-19
Thakur, A., Sharma, V., Averbek, S., Liang, L., Pandya, N., Kumar, G., Cili, A., & Zhang, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06102-6 · Cited by 15
Therapeutic potential of bixin on inflammation: a mini review
Shadisvaaran, S., Chin, K., Mohd-Said, S., & Leong, X.-F. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1209248 · Cited by 15
Raps, S., Bahr, L. L., Karkossa, I., Rossol, M., von Bergen�, M., & Schubert, K. A. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.169650 · Cited by 15
Yu, C., Li, Y., Li, Y., Li, S., Zeng, F., Yu, J., Ji, Z., Li, K., & Zhai, H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117831 · Cited by 15
Abd‐Elhakim, Y. M., Mohamed, A. A.-R., Noreldin, A. E., Khamis, T., Eskandrani, A. A., Shamlan, G. H., Alansari, W. S., Alotaibi, B. S., Alosaimi, M. E., Hakami, M. A., et al. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116869 · Cited by 15
Helicobacter pylori and gastric cancer: a lysosomal protease perspective
Soond, S. M., & Zamyatnin, A. A. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01272-8 · Cited by 16
Huang, J., Wei, S., Peng, Z., Xiao, Z., Yang, Y., Liu, J., Zhang, B., & Li, W. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab171 · Cited by 15
Katturajan, R., Nithiyanandam, S., Parthasarathy, M., Gopalakrishnan, A. V., Sathiyamoorthi, E., Lee, J., Ramesh, T., Iyer, M., Prince, S. E., & Ganesan, R. (2022) · Vaccines · doi:10.3390/vaccines10111902 · Cited by 15
Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis
Rayaprolu, S., Seven, Y. B., Howard, J. C., Duffy, C., Altshuler, M. S., Moloney, C. M., Giasson, B. I., & Lewis, J. M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.05.009 · Cited by 15
Darunavir alleviates irinotecan-induced intestinal toxicity in Vivo
Zhang, X., Zhang, G., Ren, Y., Lan, T., Li, D., Tian, J., & Jiang, W. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.044 · Cited by 14
Meng, Q., Cheng, Q., Feng, X., Chen, S., Li, Y., Zhang, G., & Nie, K. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5497078 · Cited by 15
Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection
Aslam, M., & Ladilov, Y. V. (2020) · Cells · doi:10.3390/cells9091962 · Cited by 15
Mohamed, M. M., Zaki, H. F., & Kamel, A. S. E. D. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10207-4 · Cited by 14
The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders
Sarkar, S. K., Gubert, C., & Hannan, A. J. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106276 · Cited by 15
Inflammasome Signaling and Other Factors Implicated in Atherosclerosis Development and Progression
Samani, Z. N., Sewell, R. D. E., & Rafieian‐Kopaei, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200504115045 · Cited by 14
Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2
Begum, R., Mamun-Or-Rashid, A. N. M., Lucy, T. T., Pramanik, M. K., Sil, B. K., Mukerjee, N., Tagde, P., Yagi, M., & Yonei, Y. (2022) · Molecules · doi:10.3390/molecules27206934 · Cited by 14
Wu, J., Yang, S.-M., Wu, H., Huang, Y., & Miao, Y. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.22-122 · Cited by 14
Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver
Seo, H.-Y., Lee, S. H., Park, J. Y., Han, E., Han, S., Hwang, J. S., Kim, M. K., & Jang, B. K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290532 · Cited by 13
Zhuang, C., Zhao, J., Zhang, S., & Shahid, M. S. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106338 · Cited by 14
Lv, C., Hu, C., Zhu, C., Wan, X., Chen, C., Ji, X., Qin, Y., Lü, L., & Guo, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115963 · Cited by 15
Interleukins in Epilepsy: Friend or Foe
Dong, Y., Zhang, X., & Wang, Y. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-023-01170-2 · Cited by 16
Chen, H., Sun, H., Hua, W., Chang, H., Chen, W.-J., & Ma, S. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176344 · Cited by 14
Liang, Y., Fu, J., Shi, Y., Jiang, X., Lu, F., & Liu, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27597 · Cited by 14
Ge, W., Zhang, X., Wang, Q., Jianjie, M. A. O., Jia, P., & Cai, J. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13224 · Cited by 17
Pucinelli, C. M., da Silva, R. A. B., Nelson‐Filho, P., Lima, R. B., Lucisano, M. P., Marchesan, J. T., & da Silva, L. A. B. (2024) · Clinical Oral Investigations · doi:10.1007/s00784-024-05691-6 · Cited by 14
Elmorsy, E. A., Saber, S., Hamad, R. S., Abdel‐Reheim, M. A., Nadwa, E. H., Alibrahim, A., Alkhamiss, A. S., Alsalloom, A. A., Mohamed, E. A. K., Nour-El-Din, M., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122966 · Cited by 14
The role of mitochondria in cytokine and chemokine signalling during ageing
Kalykaki, M., Rubio‐Tomás, T., & Tavernarakis, N. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111993 · Cited by 14
Fang, T., Xiong, J., Huang, X., Fang, X., Shen, X., Jiang, Y., & Lu, H. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127964 · Cited by 14
Sulfasalazine as an Immunomodulator of the Inflammatory Process during HIV-1 Infection
Feria, M. G., Rugeles, M. T., Hernández, J. C., Luján, J., & Taborda, N. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184476 · Cited by 14
Nor, M. N. M., Rupenthal, I. D., Green, C. R., & Acosta, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041755 · Cited by 14
Li, W., Shen, X., Feng, S., Liu, Y., Zhao, H., Zhou, G., Sang, M., Sun, X., Jiao, R., & Liu, F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07377-2 · Cited by 14
Cao, W., Wu, T., Liang, F., Fang, Y., Cheng, Y., Pan, S., & Xu, X. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14252 · Cited by 14
Schweiger, D. Š., Goričar, K., Hovnik, T., Mendez, A., Bratina, N., Brecelj, J., Vidan‐Jeras, B., Battelino, T., & Dolžan, V. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00063 · Cited by 14
Metadata
- Authors
- Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C.
- Affiliations
- Chungnam National University (KR)
- Chiba University (JP)
- Corresponding author
- Jo, Eun-Kyeong
- Venue
- Cellular & Molecular Immunology
- Published
- 2015-11-09
- Volume
- 13
- Issue
- 2
- Pages
- 148-159
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- PMC
- PMC4786634
- OpenAlex
- W2118918019
- Cited by
- 1,378
- References
- 139
- Citations by year
- 2026: 127 · 2025: 125 · 2024: 157 · 2023: 162 · 2022: 145 · 2021: 173 · 2020: 171 · 2019: 122 · 2018: 97 · 2017: 61 · 2016: 36
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Cellular and Molecular Immunology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- NLRP3 inflammasome, inflammasome activation, caspase-1, autoinflammatory disease, autoimmune disease, anti-inflammatory therapy, inflammasome assembly, inflammatory diseases
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Autoimmune Diseases, Cytosol, Humans, Inflammation, Signal Transduction, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review